Many tools have been developed to extract functional and mechanistic insight from bulk 32 transcriptome profiling data. With the advent of single-cell RNA sequencing (scRNA-seq), it is 33 in principle possible to do such an analysis for single cells. However, scRNA-seq data has 34 characteristics such as drop-out events, low library sizes and a comparatively large number 35 of samples/cells. It is thus not clear if functional genomics tools established for bulk 36 sequencing can be applied to scRNA-seq in a meaningful way. To address this question, we 37 performed benchmark studies on in silico and in vitro single-cell RNA-seq data. We included 38 the bulk-RNA tools PROGENy, GO enrichment and DoRothEA that estimate pathway and 39 transcription factor (TF) activities, respectively, and compared them against the tools AUCell 40 and metaVIPER, designed for scRNA-seq. For the in silico study we simulated single cells 41 from TF/pathway perturbation bulk RNA-seq experiments. Our simulation strategy guarantees 42 that the information of the original perturbation is preserved while resembling the 43 characteristics of scRNA-seq data. We complemented the in silico data with in vitro scRNA-44 seq data upon CRISPR-mediated knock-out. Our benchmarks on both the simulated and real 45 data revealed comparable performance to the original bulk data. Additionally, we showed that 46 the TF and pathway activities preserve cell-type specific variability by analysing a mixture 47 sample sequenced with 13 scRNA-seq different protocols. Our analyses suggest that bulk 48 functional genomics tools can be applied to scRNA-seq data, outperforming dedicated single 49 cell tools. Furthermore we provide a benchmark for further methods development by the 50 community. 51 3
We first benchmarked the tools on simulated single cell transcriptome profiles. We found that 99 on this in silico data the gene sets from DoRothEA and PROGENy can functionally 100 characterize simulated single cells. We observed that the performance of the different tools is 101 dependent on the used statistical method and properties of the data, such as library size or 102 number of cells. We then used real scRNA-seq data upon CRISPR-mediated knock-103 out/knock-down of TFs [19, 20] to assess the performance of DoRothEA's gene sets. The 104 results of this benchmark further supported our finding that functional genomics tools can 105 provide accurate mechanistic insights into single cells. We observed different performance by 106 the different tool on this task dependent on the statistical approach used. Finally, we 107 demonstrated the utility of the tools for pathway and TF activity estimation on recently 108 published data profiling a complex sample with 13 different scRNA-seq technologies [21] . 109 Here, we showed that summarizing gene expression into TF and pathway activities preserves 110 cell type specific information. Collectively, our results suggest that the bulk based functional 111 analysis tools DoRothEA and PROGENy outperform the single cell tools AUCell and 112 metaVIPER. Although on scRNA-seq data DoRothEA and PROGENy were less accurate than 113 on bulk RNA-seq, we were still able to extract relevant functional insights from scRNA-seq 114
data. 115
Results 116
Robustness of bulk RNA based functional genomics tools against low gene coverage 117
Single-cell RNA-seq profiling is hampered by low gene coverage due to drop-out events [22] . 118 In our first analysis we focused solely on the low gene coverage aspect and whether tools 119 designed for bulk can deal with it. Specifically, We aimed to explore how DoRothEA, 120
PROGENy and GO gene sets combined with GSEA (GO-GSEA) can handle low gene 121 coverage in general, independently of other artefacts and characteristics from scRNA-seq 122 protocols. Thus, we conducted this benchmark using bulk transcriptome benchmark data. In 123 these studies, TFs and pathways are perturbed experimentally, and the transcriptome profile 124
is measured before and after the perturbation. These experiments can be used to benchmark 125 tools for TF/pathway activity estimation, as they should estimate correctly the change in the 126 perturbed TF or pathway. The use of these datasets allowed us to systematically control for 127 the gene coverage (see Methods). The workflow consisted in four steps (Fig. S1a ). In the first 128 step we summarized all perturbation experiments into a matrix of contrasts (with genes in rows 129
and contrasts in columns) by differential gene expression analysis. Subsequently, we 130 randomly replaced, independently for each contrast, logFC values with 0 so that we obtain a 131 predefined number of "covered" genes with a logFC unequal to zero. Accordingly, a gene with 132 a logFC = 0 was considered as missing/not covered. Afterwards we applied DoRothEA, 133
PROGENy and GO-GSEA on the contrast matrix, subsetted only to those experiments which 134 are suitable for the corresponding tool: TF perturbation for DoRothEA and pathway 135 perturbation for PROGENy and GO-GSEA. We finally evaluate the global performance of the 136 methods with Receiver operating characteristic (ROC) and precision recall (PR) curves (see 137
Methods). This process was repeated 25 times to account for stochasticity effects during 138
inserting zeros in the contrast matrix (see Methods). 139 140
DoRothEA's TFs are accompanied by an empirical confidence level indicating the confidence 141 in their regulons, ranging from A (most confident) to E (less confident) (see Methods). For this 142 benchmark we included only TFs with confidence level A and B (denoted as DoRothEA (AB)) 143
as this combination has a reasonable tradeoff between coverage and performance [12] . In 144 general, the performance of DoRothEA dropped as gene coverage decreased. While it 145
showed reasonable prediction power with all available genes (AUROC of 0.690), it 146 approached almost the performance of a random model (AUROC of 0.5) when only 500 genes 147
were covered (mean AUROC of 0.547; Fig. 1a , and similar trend with AUPRC, Fig. S1c ). 148 149 We next benchmarked pathway activities estimated by PROGENy and GO-GSEA. In the 150 original PROGENy framework, 100 footprint genes are used per pathway to compute pathway 151 activities by default, as it has been shown that this leads to the best performance on bulk 152
samples [11] . However, one can extend the footprint size to cover more genes of the 153 expression profiles. We reasoned that this might counteract low gene coverage, and 154
implemented accordingly different PROGENy versions (see Methods). With the default 155 PROGENy version (100 footprint genes per pathway) we observed a clear drop in 156 performance with decreasing gene coverage, even though less drastic than for DoRothEA 157 (from AUROC of 0.724 to 0.636; Fig. 1b ; similar trends with AUPRC; Fig. S1d ). As expected, 158
PROGENy performed the best with 100 footprint genes per pathway when there is complete 159 gene coverage. The performance differences between the various PROGENy versions shrank 160 with decreasing gene coverage. This suggests that increasing the number of footprint genes 161
can help to counteract low gene coverage. To provide a fair comparison between PROGENy 162
and GO-GSEA we used only those 14 GO terms that match the 14 PROGENy pathways (Fig. 163 S1b). In general GO-GSEA showed weaker performance than PROGENy. The decrease in 164 performance was more prominent as gene coverage decreased (from AUROC of 0.662 to 165 0.525; Fig. 1c and similar trend with AUPRC, Fig. S1e ). With a gene coverage of less than 166
2000 genes, GO-GSEA performance was no better than random. 167 168
In summary, this first benchmark provided insight into the general robustness of the bulk based 169 tools DoRothEA, PROGENy and GO-GSEA with respect to low gene coverage. DoRothEA 170 performed reasonably well down to a gene coverage of 2000 genes. The performance of all 171 different PROGENy versions were robust across the entire gene coverage range tested. GSEA showed a worse performance than PROGENy, especially in the low gene coverage 173 range. Since DoRothEA and PROGENy showed promising performance in low gene coverage 174 ranges, we decided to explore them on scRNA-seq data. Due to its poor performance, we did 175 not include GO-GSEA in the subsequent analyses. The simulation workflow started by transforming read counts of a single bulk RNA-seq sample 205
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Benchmark of bulk and single-cell functional genomics tools on simulated scRNA-seq
to transcripts per million (TPM), normalizing for gene length and library size. Subsequently, 206
for each gene, we assigned a sampling probability by dividing the individual TPM values with 207 the sum of all TPM values. These probabilities are proportional to the likelihood for a given 208 gene not to "drop-out" when simulating a single cell from the bulk sample . We determined the  209  library size by sampling from a normal distribution with mean equal to the desired library size.  210  For every single cell, we sampled with replacement genes from the gene probability vector up  211  to the determined library size. The number of individual gene samples denote the new gene  212  count in the single cell. The number of simulated single cells from a bulk sample is a parameter  213 of the simulation ( Fig. 2a Methods). We repeated the simulation of numerous single cells from each bulk sample 220 template to account for the stochasticity of the simulation procedure. We tested our simulation 221 strategy by comparing the characteristics of the simulated cells to real single cells. We 222 compared the count distribution ( Fig. S3a and b ), the relationship of mean and variance of 223 gene expression ( Fig. S3c and d ) and the relationship of library size to number of detected 224 genes ( Fig. S3e and f). These comparisons suggested that our simulated single cells closely 225 resemble real single cells and are thus suitable for benchmarking. 226 227
Unlike in our first benchmark, we applied the functional genomics tools directly on single 228 samples/cells and built the contrasts at the level of pathway and TF activities (see Methods). 229 We compared the performance of all tools to recover the perturbed TFs/pathways. We also 230 considered the performance of the bulk based tools DoRothEA and PROGENy on the 231 template bulk data as a baseline for comparison to their respective performance on the single 232 cell data. 233 234 We show, as an example, the workflow of the performance evaluation for DoRothEA ( Fig. 2b ). 235
As a first step we applied DoRothEA to single cells generated for one specific parameter 236 combination (number of cells = 10, mean library size = 5000) and bulk samples, performed 237 differential activity analysis (see Methods), and evaluated the performance with ROC and PR 238 curves including only TFs with confidence level A. Each repetition of the simulation is depicted 239 by an individual ROC curve, which shows the variance in performance of DoRothEA on 240 simulated single cell data ( Fig. 2b -1 . step). The variance decreases as the library size and 241 the number of cells increase (which holds true for all tested tools; Fig. S4a-e ). The shown ROC 242 curves are summarized into a single AUROC value for bulk, and mean AUROC value for single 243 cells. We performed this procedure also for different TF confidence level combinations and 244
show the performance change in these values in relation to the TF coverage ( Fig. 2b -2 . step). 245
For both bulk and single cells, we observe a tradeoff between TF coverage and performance 246 caused by including different TF confidence level combinations in the benchmark. This result 247 is supported by both AUROC and AUPRC ( Fig. S5a ) and correspond to our previous findings 248 [12] . The performance of DoRothEA on single cells does not reach the performance on bulk, 249 though it can still recover TF perturbations on the simulated single cells reasonably well. This 250 is especially true for the most confident TFs (AUROC of 0.690 for confidence level A and 0.682 251 for the confidence level combination AB). Finally we explore the effect of the library size and 252 the number of cells on the performance by performing the previously described analysis for all 253 combinations of library sizes and cell numbers. We computed the mean difference between 254
AUROC scores of single cell and bulk data for all confidence level combinations. We observed 255 a gradually decreasing differences when the size of the library and the number of cells 256 increase ( Fig. 2b -3 . step and Fig. S6a ). Note, however, that the number of cells has a stronger 257 impact on the performance than the mean library size. This analysis identified the best 258 performing combination of DoRothEA's TF confidence levels for different library sizes and 259 number of single cells. Thus, the results can be used as recommendations for choosing the 260 confidence levels on data from an experiment with comparable characteristics in terms of cell 261 numbers and sequencing depths. 262 263
Similarly to DoRothEA, we also observed for D-AUCell a tradeoff between TF coverage and 264 performance for both single cells and bulk samples when using the same parameter 265 combination ( Fig. 2c ; similar trend with AUPRC Fig. S5b ). The summarized performance 266 across all confidence level combinations of D-AUCell on single cells slightly outperformed its 267 performance on bulk samples (AUROC of 0.601 on single cells and 0.597 on bulk). This trend 268
becomes more evident with increasing library size and number of cells ( Fig. S6b ). 269
For the benchmark of metaVIPER we assigned confidence levels to the tissue specific GTEx 270 regulons based on DoRothEA's gene set classification. This was done for consistency with 271
DoRothEA and D-AUCell, even if there is no difference in confidence among them. Hence, for 272 metaVIPER, we do not observe a tradeoff between TF coverage and performance ( Fig. 2d ; 273 similar trend with AUPRC Fig. S5c ). As opposed to D-AUCell, metaVIPER performed better 274 on single cells than on bulk samples across all confidence level combinations (AUROC of 275 0.584 on single cells and 0.531 on bulk). This trend increased with increasing library size and 276 number of cells ( Fig. S6c ). However, the overall performance of metaVIPER is worse than the 277 performance of DoRothEA and D-AUCell. In summary, the bulk based tool DoRothEA 278 performed the best on the simulated single cells followed by D-AUCell. metaVIPER performed 279 slightly better that a random model. 280
For the benchmark of PROGENy we observed that it performed well across different number 281 of footprint genes per pathway, with a peak at 500 footprint genes for both single cells and 282 bulk (AUROC of 0.856 for bulk and 0.831 for single cells; Fig. 2e -similar trend with AUPRC 283 Fig. S5d ). A higher performance for single cell analysis with more than 100 footprint genes per 284 pathway is in agreement with the previous general robustness study that suggested that a 285 higher number of footprint genes can counteract low gene coverage. Increasing the library 286 size and the number of cells improved the performance of PROGENy on single cells reaching 287 almost the same performance as on bulk samples ( Fig. S6d ). For most parameter 288 combinations, PROGENy with 500 or 1000 footprint genes per pathway yields the best 289 performance. 290 291
For P-AUCell we observed a different pattern than for PROGENy as it worked best with 100 292 footprint genes per pathway for both single cells and bulk (AUROC of 0.788 for bulk and 0.712 293 for single cells; Fig. 2f -similar trends with AUPRC Fig. S5e ). Similar to PROGENy, increasing 294 the library size and the number of cells improved the performance, but not to the extent of its 295 performance on bulk ( Fig. S6e ). For most parameter combinations P-AUCell with 100 or 200 296 footprint genes per pathway yielded the best performance. 297 298
In summary, both PROGENy and P-AUCell performed well on the simulated single cells, and 299
PROGENy performed slightly better. For the pathway analysis the P-AUCell did not perform 300 better on scRNA-seq than on bulk data. We then went on to perform a benchmark analysis on 301 real scRNA-seq datasets. 302 
328
Benchmark of bulk and single-cell functional genomics tools on real scRNA-seq data 329
After showing that the gene sets from DoRothEA and PROGENy can handle low gene 330 coverage and work reasonably well on simulated scRNA-seq data with different statistical 331 approaches, we performed a benchmark on real scRNA-seq data. However, single cell 332 transcriptome profiles of TF and pathway perturbations are very rare. To our knowledge there 333 are no datasets of pathway perturbations on single cell level comprehensive enough for a 334 robust benchmark of pathway analysis tools. For tools inferring TF activities the situation is 335 better: recent studies combined CRISPR knock-outs/knock-down of TFs with scRNA-seq 336 technologies [19, 20] , that can serve as potential benchmark. 337
The first dataset is based on the Perturb-seq technology, which contains 26 knock-out 338 perturbations targeting 10 unique TFs after 7 and 13 days of perturbations ( Fig. S7a) [19]. To 339 explore the effect of perturbation time we divided the dataset into two sub datasets based on 340 perturbation duration (Perturb-seq (7d) and Perturb-seq (13d)). The second dataset is based 341
on CRISPRi protocol and contains 141 perturbation experiments targeting 50 unique TFs [20] 342 (Fig. S7a) . The datasets showed a variation in terms of drop-out rate, number of cells and 343 sequencing depths ( Fig. S7b ). 344 345
To exclude bad or unsuccessful perturbations in case of CRISPRi experiments, we discarded 346 experiments when the logFC of the targeted gene/TF was greater than 0 (12 out of 141; Fig.  347 S7c). This quality control is important only in the case of CRISPRi, as it works on the 348 transcriptional level. Perturb-seq (CRISPR knock-out) acts on the genomic level, so we can 349 not expect a clear relationship between KO efficacy and transcript level of the target. Note that 350 the logFC's of both Perturb-seq sub datasets are in a narrower range in comparison to the 351 logFCs of the CRISPRi dataset ( Fig. S7d ). The perturbation experiments which passed this 352 quality check were used in the following analyses. 353 354 We evaluated the performance of DoRothEA, D-AUCell and metaVIPER on each benchmark 355 dataset individually. We found that DoRothEA outperformed D-AUCell and metaVIPER across 356 different combinations of DoRothEA confidence levels on Perturb-seq (7d) and CRISPRi 357 dataset ( Fig. 3a ). metaVIPER did not perform better than a random model for these datasets. 358 Interestingly, the performance of all three methods on the Perturb-seq (13d) dataset was very 359 weak independently of DoRothEA's confidence level (Fig. 3a) . The captured trends are also 360 reported in PR-space ( Fig. S7e ). 361
In summary, these analyses suggested that DoRothEA is the best-performing method to 362 recover TF perturbation at the single cell level on in vitro data. 363 
367
Application of bulk and single-cell functional genomics tools to samples of 368 heterogeneous cell type populations (PBMC+HEK293T) 369
In our last analysis we wanted to test the performance of all tested tools in a more 370
heterogeneous system that would illustrate a typical scRNA-seq data analysis scenario where 371 multiple cell types are present. We used a dataset from the Human Cell Atlas project [23] that 372 contains scRNA-seq profiles of human Peripheral blood mononuclear cells (PBMCs) and 373
HEK293T with annotated cell types [21] . This dataset was analysed with 13 different scRNA-374 seq protocols (see Methods). In this study no ground truth (in contrast to the previous 375 perturbation experiments) for TF and pathway activities were available. To evaluate the 376 performance of all methods, we assessed the potential of TF and pathway activity estimations 377 to cluster cells from the same cell type together based on a priori annotated cell types. We 378 performed our analysis for each scRNA-seq technology separately to identify protocol-specific 379 and protocol-independent trends. We assumed that the cell-type information should be 380 preserved also on the reduced dimension space of TF / pathway activities, if these 381 meaningfully capture the corresponding functional processes. Hence, we assessed how well 382 the individual clusters correspond to the annotated cell types by a two-step approach. First we 383 applied UMAP on different input matrices e.g. TF/pathway activities or gene expression and 384 then we evaluated how well cells from the same cell type cluster together. We considered 385 silhouette widths as a metric of cluster purity (see Methods we decided to evaluate the cluster purity at different levels of the cell-type hierarchy from fine-401 grained to coarse-grained. We start with the hierarchy level 0 where every cell type forms a 402 distinct cluster and end with hierarchy level 4, where all PBMC cell types and all cell lines form 403 a distinct cluster (Fig. 4a ). 404 405
To evaluate the performance of the TF activity inference methods and the utility of TF activity 406 scores, we determined the cluster purity derived from TF activities (using only DoRothEA TFs 407 with confidence level A and B), TF expression, positive and negative control. Both scRNA-seq 408 protocols and matrices used for dimensionality reduction affected cluster purity significantly 409
(2-way ANOVA p-values <2.2e-16 and 1.4e-10, respectively, p-values and estimations for 410 corresponding linear model coefficients in Fig. S9a ; see Methods). The cluster purity based 411 on TF activities inferred using DoRothEA and D-AUCell did not differ significantly (Fig. 4b,  412 corresponding plots for all hierarchy levels in Fig. S9b ). In addition the cluster purity of both 413 tools were not significantly worse that the purity based on all 2000 HVGs, though we observed 414 a slight trend indicating a better cluster purity based on HVGs. This trend is expected due to 415 the large difference of available features for dimensionality reduction. Instead a comparison 416
to the positive and negative control is more appropriate. Both DoRothEA and D-AUCell 417 performed comparably to the positive control but significantly better than the negative control 418 across all scRNA-seq protocols (TukeyHSD post hoc test, adj. p-value of 1.05e-4 for 419
DoRothEA and 5.7e-4 for D-AUCell). The cluster purity derived from metaVIPER was 420 significantly worse than for DoRothEA (adj. p-value of 0.0423) and tend to be worse than D-421
AUCell (TukeyHSD post hoc test, adj. p-value of 0.130) as well. Also metaVIPER wasn't better 422 than than the negative control. Regardless of the underlying TF activity inference method, the 423 cluster purity derived from TF activities outperformed the purity derived from TF expression 424 (adj. p-value of 5.42e-6 for DoRothEA, 3.33-e5 for D-AUCell and 0.146 for metaVIPER). This 425 underlines the advantage and relevance of using TF activities over the expression of the TF 426 itself (Fig. 4c ). With a comparable performance to a similar number of HVG and also to 2000 427
HVGs, we concluded that TF activities serve -independently of the underlying scRNA-seq 428 protocol -as a complementary approach for cluster analysis that is based on generally more 429 interpretable cell type marker. 430 431
To evaluate the performance of pathway inference methods and the utility of pathway activity 432 scores we determined cluster purity with pathway matrices generated with different methods. 433 We used 200 and 500 footprint genes per pathway for PROGENy and P-AUCell, respectively, 434 since they provided the best performance in the previous analyses. As observed already 435 before, both scRNA-seq protocols and matrices used for dimensionality reduction affected 436 cluster purity significantly (2-way ANOVA p-values of 2.84e-7 and 1.13e-13, respectively, p 437 values and estimations for corresponding linear model coefficients in Fig.S10b ; see Methods). 438
The cluster purity derived from pathway activity matrices is not significantly different 439
PROGENy and P-AUCell, while worse than all HVGs (adj. p-value of 4.07e-10 for PROGENy 440 and 4.59e-9 for P-AUCell; Fig. 4d , corresponding plots for all hierarchy levels in Fig. S9b ). 441
This is expected due to the large difference in the number of available features for 442 dimensionality reduction (2000 HVGs vs 14 pathways). The cluster purity of both approaches 443 was comparable to the positive control but significantly better than the negative control (adj. 444 p-value of 0.077 for PROGENy and 0.013 for P-AUCell vs. negative control). In summary, this 445 study indicated that the pathway activities contain relevant and cell-type specific information, 446 even though they do not capture enough functional differences to be used for effective 447 clustering analysis. Overall, the cluster purity of cells represented by the estimated pathway 448 activities is worse than the cluster purity of cells represented by the estimated TF activities 449
[21]. In addition we observed that input matrices derived from Quartz-Seq2 protocol yielded 450
for hierarchy level 2 in significantly better cluster purity than all other protocols which is in 451 agreement with the original study of of the PBMC + HEK293T data ( Fig. S9a and S10a) [21] . 452 453 TF and pathway activity scores are more interpretable than expression of single genes. Hence, 454
we were interested to explore whether we could recover known cell-type specific TF and 455 pathway activities from the PBMC data. We decided to focus on the dataset measured with 456
Quartz-Seq2 as this protocol showed superior performance over all other platforms [21] . We In summary, the analysis of this mixture sample demonstrated that summarizing gene 474 expression into TF activities can preserve cell type specific information while drastically 475 reducing the number of features. Hence, TF activity matrices could be considered as an 476 alternative to full gene expression matrix for clustering analysis. We also showed that pathway 477 activity matrices contain cell-type specific information, too, although we do not recommend 478
using them for clustering analysis as the number of features is too low. In addition, we 479 recovered known pathway/TF cell-type associations showing the importance of directionality 480 and supporting the utility and power of the functional genomics tools DoRothEA and 481
PROGENy. 482 In this paper we tested the robustness and applicability of functional genomics tools on 496 scRNA-seq data. We included both bulk-and single-cell-based functional genomics tools that 497 estimate either TF or pathway activities from gene expression data and for which well-defined 498 benchmark data exist. The bulk based tools were DoRothEA, PROGENy and GO gene sets 499 analysed with GSEA (GO-GSEA). The functional genomics tools specifically designed for the 500 application in single cells were the statistical method AUCell combined with DoRothEA (D-501
AUCell) and PROGENy (P-AUCell) gene sets and metaVIPER. 502 503
We first explored the effect of low gene coverage in bulk data on the performance of the bulk 504 based tools DoRothEA, PROGENy and GO-GSEA. We found that for all tools the performance 505 dropped with decreasing gene coverage but at a different rate. While PROGENy was robust 506 down to 500 covered genes, DoRothEA's performance dropped markedly at 2000 covered 507
genes. In addition, the results related to PROGENy suggested that increasing the number of 508 footprint genes per pathway counteracted low gene coverage. GO-GSEA showed the 509 strongest drop and did not perform better than a random guess below 2000 covered genes. 510
Comparing the performance of both pathway analysis tools suggests that footprint based gene 511 sets are superior over gene sets containing pathway members (e.g. GO gene sets) in 512 recovering perturbed pathways. This observation is in agreement with previous studies 513 conducted by us and others [11, 30] . Given this fact and that GO-GSEA cannot handle low 514 gene coverage (in our hands) we concluded that this approach is not suitable for scRNA-seq 515
analysis. Hence, we decided to focus only on PROGENy as bulk based pathway analysis tool 516 for the following analyses. 517 518
Afterwards, we benchmarked DoRothEA, PROGENy, D-AUCell, P-AUCell and metaVIPER 519 on simulated single cells which we sampled from bulk pathway/TF perturbation samples. We 520
showed that our simulated single cells possess characteristics comparable to real single cell 521 data, supporting the relevance of this strategy. Different combinations of simulation 522 parameters can be related to different scRNA-seq technologies. For each combination we 523 provide a recommendation of how to use DoRothEA's and PROGENy's gene sets (in terms 524 of confidence level combination or number of footprint genes per pathway) to yield the best 525 performance. It should be noted that our simulation approach, as it is now, allows only the 526 simulation of a homogenous cell population. This would correspond to a single cell experiment 527
where the transcriptome of a cell line is profiled. In future work this simulation strategy could 528 be adapted to account for a heterogeneous dataset which would resemble more realistic single 529 cell datasets [31] . 530 531
In terms of TF activity inference, DoRothEA performed best on the simulated single cells 532 followed by D-AUCell and then metaVIPER. Both DoRothEA and D-AUCell shared 533
DoRothEA's gene set collection but applied different statistics. Thus, we concluded that, in our 534 data, VIPER is more suitable to analyse scRNA-seq data than AUCell. resources with in silico predicted resources. Moreover, we hypothesize based on the pairwise 544 comparison that for functional genomics analysis the choice of gene sets is of higher relevance 545 than the choice of the underlying statistical method. 546 547
Related to pathway analysis, both PROGENy and P-AUCell performed well on the simulated 548 single cells. The original framework of PROGENy uses a linear model that incorporates 549 individual weights of the footprint genes, denoting the importance and also the sign of the 550 contribution (positive/negative) to the pathway activity score. Those weights cannot be 551 considered when applying AUCell with PROGENy gene sets. The slightly higher performance 552
of PROGENy suggests that individual weights assigned to gene set members can improve 553 the activity estimation of biological processes. 554
Especially in the benchmark of both TF analysis methods we observed that the D-AUCell and 555 metaVIPER performed better on single cells than on the original bulk samples. This trend 556
becomes more pronounced with increasing library size and number of cells. However, the bulk 557 based tools perform better on single cells than the scRNA specific tools for both benchmarks. 558 559
Subsequently, we aimed to validate the aforementioned tools on real single cell data. While 560
we could not find suitable benchmark data of pathway perturbations, we exploited two 561 independent datasets of TF perturbations to benchmark the TF activity inference methods. 562
These datasets combined CRISPR-mediated TF knock-out/knock-down (Perturb-Seq and 563
CRISPRi) with scRNA-seq. It should be noted that pooled screenings of gene knock-outs with 564
Perturb-seq suffer from an often faulty assignment of guide-RNA and single cell [34] . Those 565 mislabeled data confound the benchmark as the groundtruth is not reliable. Nevertheless, we 566 showed that DoRothEA's gene sets were globally effective in inferring TF activity from single 567 cell data with varying performance dependent on the used statistical method. As already 568
shown in the in silico benchmark D-AUCell showed a weaker performance than DoRothEA, 569 supporting that VIPER performs better than AUCell. Interestingly, metaVIPER's performance 570 was no better than random across all datasets. metaVIPER used the same statistical method 571
as DoRothEA but different gene set resources. This further supports our hypothesis that the 572 selection of gene sets is more important than the statistical method for functional genomics 573 analysis. 574 575
Furthermore, the perturbation time had a profound effect on the performance of the tools: while 576
DoRothEA and D-AUCell worked well for a perturbation duration of 6 (CRISPRi) and 7 days 577 (Perturb-Seq (7d)), the performance dropped markedly for 13 days. 578
We reasoned that, within 13 days of perturbation, compensation effects are taking place at 579 the molecular level that confound the prediction of TF activities. In addition, it is possible that 580 cells without a gene edit outgrow cells with a successful knock-out after 13 days as the knock-581 out typically yield in a lower fitness and thus proliferation rate. 582 583
In summary, DoRothEA subsetted to confidence levels A and B performed the best on real 584 scRNA-seq data but at the cost of the TF coverage. The results of the in silico and in vitro 585 benchmark are in agreement. Accordingly, we believe that it is reasonable to assume that also 586 PROGENy works on real data given the positive benchmark results on simulated data. 587 588
Finally, we applied our tools of interest to a mixture sample of PBMCs and HEK cells profiled 589 with 13 different scRNA-seq protocols. We investigated to which extent pathway and TF 590 matrices retain cell-type specific information, by evaluating how well cells belonging to the 591 same cell type or cell type family cluster together in reduced dimensionality space. Given the 592 lower numbers of features available for dimensionality reduction using TF and pathway 593 activities, cell types could be recovered equally well as when using the same number of the 594 top highly variable genes. In addition, we showed that cell types could be recovered more 595 precisely using TF activities than TF expression, which is in agreement with previous studies 596
[18]. This suggests that summarising gene expression as TF and pathway activities can lead 597 to noise filtering, particularly relevant for scRNA-seq data. Though, TF activities performed 598 better than pathway activities which is again attributed to the even lower number of pathways. 599 600
Our analysis suggested at different points that the performance of functional genomics tools 601
is more sensitive to the selection of gene sets than the statistical methods. This hypothesis 602 could be tested in future by decoupling functional genomics tools into gene sets and statistics. 603
Benchmarking all possible combinations of gene sets and statistic (i.e. DoRothEA gene sets 604 with a linear model or PROGENy gene sets with VIPER) would shed light on this question 605 which we believe if of high relevance for the community. 606
Conclusions 607
Our systematic and comprehensive benchmark study suggests that DoRothEA and 608
PROGENy are effective in inferring TF and pathway activity from scRNA-seq data, 609
outperforming tools specifically designed for scRNA-seq analysis. We showed the limits of 610 both tools with respect to low gene coverage and also provided as part of the in silico 611 benchmark recommendations on how to use DoRothEA's and PROGENy's gene sets in the 612 best way dependent on the number of cells and mean library size. These two parameters are 613 technology specific, so that our recommendations are transferable to various scRNA-seq 614
protocols. Furthermore, we showed that TF and pathway activities are rich in cell type specific 615 information with reduced amount of noise and provide an intuitive way of interpretation and 616 hypothesis generation. We provide our benchmarks and code to the community for further 617 assessment of methods for functional analysis. 618
Methods 619
PROGENy 620
PROGENy is a functional genomics tool which infers pathway activity for 14 signaling 621 pathways (Androgen, Estrogen, EGFR, Hypoxia, JAK-STAT, MAPK, NFkB, PI3K, p53, TGFb, 622
TNFa, Trail, VEGF and WNT) from gene expression data [11, 35] . Pathway activity inference 623 is based on gene sets comprising the top 100 most responsive genes upon corresponding 624
pathway perturbation, which we refer to as footprint genes of a pathway. 625 626 DoRothEA 627 DoRothEA is a data resource containing signed transcription factor (TF) -target interactions 628
[12]. Those interactions were curated and collected from different types of evidence such as 629 literature curated resources, ChIP-seq peaks, TF binding site motifs and interactions inferred 630 directly from gene expression. Based on the number of supporting evidences each interaction 631
is accompanied with an interaction confidence score ranging from A-E, with A being the most 632 confidence interactions. In addition a summary TF confidence score is assigned (also from A-633 E) which is derived by and subsetted to the leading confidence level of its interactions. 634
DoRothEA contains in total 470,711 interactions covering 1,396 TF targeting 20,238 unique 635 genes. We use VIPER in combination with DoRothEA to estimate TF activities from gene 636 expression data. 637 VIPER 638 VIPER is a statistical framework which was developed to estimate protein activity from gene 639 expression data using enriched regulon analysis performed by the algorithm aREA [14] . It 640 requires information about (if possibly) signed interactions between a protein and its functional 641 targets. In the original workflow this regulatory network was inferred from gene expression by 642 the algorithm ARACNe [32]. However, it can be replaced by any other data resource reporting 643 protein target interactions. 644
Simulation of single cells 645
Let C be a vector representing counts per gene for a single bulk sample. C is normalized for 646 gene length and library size resulting in vector B containing TPM values per gene. We assume 647 that samples are obtained from homogenous cell populations and that the probability of a 648 dropout event is proportional to the relative TPM of each measured gene in the bulk sample. 649
Therefore, we define a discrete cumulative distribution function from the vector of gene 650 frequencies = $ |$| . To simulate a single cell from this distribution, we draw and aggregate L 651 samples by inverse transform sampling. L corresponds to the library size for the count vector 652
of the simulated single cell. We draw L from a normal distribution ( , * + ). 653
To benchmark the robustness of the methods, we vary the number of cells sampled from a 654 single bulk sample (1, 10, 20, 30, 50, 100) and the value of μ (1000, 2000, 5000, 10.000, 655 20.000). To account for stochasticity effects during sampling we repeat this analysis 25 times 656 for each parameter combination. 657
Prior to normalization we discarded cells with a library size lower than 100. We normalized the 658 count matrices of the simulated cells by using the R package scran (version 1.11.27) [36] . 659
Contrast matrices were constructed by comparing cells originating from one of the perturbation 660 bulk samples vs cells originating from one of the control bulk samples. 661
Induction of artificial low gene coverage in bulk microarray data 662
We induce the reduction of gene coverage with inserting zeros on the contrast level. In detail 663
we insert for each contrast separately randomly zeros until we obtained a predefined number 664 of genes with a logFC unequal zero which we consider as "covered"/"measured" genes. We 665 perform this analysis for a gene coverage of 500, 1000, 2000, 3000, 5000, 7000, 8000 and as 666 reference all available genes. To account for stochasticity effects during inserting randomly 667 zero we repeat this analysis 10 times for each gene coverage value. 668
Application of PROGENy on single samples and contrasts
669
We applied PROGENy on matrices of single samples (genes in rows and either bulk samples 670 or single cells in columns) containing normalized gene expression scores or on contrast 671 matrices (genes in rows and summarized perturbation experiments into contrasts in columns) 672
containing log fold changes. In case of single sample analysis the contrasts were built based 673 on pathway activity matrices yielding the change in pathway activity (perturbed samples -674 control sample) summarized as logFC. Independent of input matrix we scaled each pathway 675
to have a mean activity of 0 and a standard deviation of 1. 676
We build different PROGENy versions by varying the number of footprint genes per pathway 677 (100, 200, 300, 500, 1000 or all which corresponds to ~29,000 genes). 678
Application of VIPER on single samples and contrasts 679
We applied VIPER with DoRothEA as regulatory network resource on matrices of single 680 samples (genes in rows and either bulk samples or single cells in columns) containing 681 normalized gene expression scores scaled gene-wise to a mean value of 0 and standard 682 deviation of 1 or on contrast matrices (genes in rows and summarized perturbation 683 experiments into contrasts in columns) containing log fold changes. In case of single sample 684 analysis the contrasts were built based on TF activity matrices yielding the change in TF 685 activity (perturbed samples -control sample) summarized as logFC. TFs with less than 4 686 targets listed in the corresponding input matrix were discarded from the analysis. VIPER 687 provides a NES enrichment score for each TF which we consider as a metric for the activity. 688 We used the R package viper (version 1.17.0) [14] to run VIPER in combination with 689
DoRothEA. 690 691 692 We applied GSEA with gene sets on contrast matrices (genes in rows and summarized 693 perturbation experiments into contrasts in columns) containing log fold changes that serve 694 also a gene level statistic. We selected only those GO terms which map to PROGENy 695 pathways in order to guarantee a fair comparison between both methods. For the enrichment 696 analysis we used the R package fgsea 
Application of GSEA with GO gene sets on contrasts
Collecting, curating and processing of microarray data 744
We extracted single pathway and single TF perturbation data profiled with classical 745 microarrays from a previous study conducted by us [35] . We followed the same procedure of 746 collection, curating and processing the data as described in the previous study. 747
Collecting, curating and processing of bulk RNA-seq data 748
For the simulation of single cells we collected, curated and processed single TF and single 749 pathway perturbation data profiled with bulk RNA-seq. . We obtained data of both replicates from GEO 774 (GSM3630200, GSM3630201), which include sgRNA counts next to the rest of the 775 transcription. We refrained from using the targeted sequencing of the sgRNA in GSM3630202, 776 GSM3630203 as it contained less clear mappings due to amplification noise. Expression data 777 lacked information on mitochondrial genes and therefore no further quality filtering of cells was 778 performed. From this dataset, only sgRNAs detected in at least 100 cells were used. A 779 combined 5282 cells remained for benchmarking. 780
Analysis was limited to the 10000 most expressed genes for all three datasets. 781 We normalized the count matrices for each individual dataset (Perturb-Seq (7d), Perturb-Seq 782 (13d) and CRISPRi) separately by using the R package scran (version 1.11.27) [36] . 783
Collecting, curating and processing of scRNA-seq data from cell atlas project 784
This scRNA-seq dataset originates from a benchmark study of the Human Cell Atlas project 785 [21] . At the time of writing this dataset is not publicly available but will be accessible from Gene 786
Expression Omnibus in the near future (GSE133549). The dataset consists of a PBMC's and 787 a HEK293T sample which was analyzed with 13 different scRNA-seq technologies (CEL-788
Seq2, MARS-Seq, Quartz-Seq2, gmcSCRB-Seq, ddSEQ, ICELL8, C1HT-Small, C1HT-789
Medium, Chromium, Chromium(sn), Drop-seq, inDrop). Most cells are annotated with a 790 specific cell type/cell line (CD4 T cells, CD8 T cells, NK cells, B cells, CD14+ Monocytes, 791 FCGR3A+ Monocytes, Dendritic cells, Megakaryocytes, HEK cells). Cells without annotation 792
were discarded for this analysis. 793 We normalized the count matrices for each technology separately by using the R package 794 scran (version 1.11.27) [36] . 795
Dimensionality reduction with UMAP and assessment of cluster quality 796
We used the R package umap (version 0.2.0.0) calling the Python implementation of Uniform 797
Manifold Approximation and Projection (UMAP) with the argument "method = 'umap-learn'" to 798 perform dimensionality reduction on various input input matrices (gene expression matrix, 799 pathway/TF activity matrix, etc.). We assume that the dimensionality reduction will result in 800 clustering of cells that corresponds well to the cell type/cell type family. To assess the validity 801 of this assumption, we assigned a cell-type/cell family specific cluster id to each point in the 802 low-dimensional space. We then defined a global cluster purity measure based on silhouette 803
widths [43] , which is a well known clustering quality measure. 804
Given the cluster assignments, in the low-dimensional space, for each cell the average 805 distance (a) to the cells that belong to the same cluster is calculated. Then the smallest 806 average distance (b) to all cells belonging to the newest foreign cluster is calculated. The 807 difference, between the latter and the former indicates the width of the silhouette for that cell, 808
i.e. how well the cell is embedded in the assigned cluster. To make the silhouette widths 809 comparable, they are normalized by dividing the difference with the larger of the two average 810 distances = ./0 102(0,.)
. Therefore, the possible values for the silhouette widths lie in the range 811 -1 to 1, where higher values indicate good cluster assignment, while lower values close to 0 812 indicate poor cluster assignment. Finally, the average silhouette width for every cluster is 813 calculated, and averages are aggregated to obtain a measure of the global purity of clusters. 814
For the silhouette analysis we used the R package cluster (version 2.0.8). 815
For statistical analysis of cluster quality, we fitted a linear model score=f(scRNA-seq protocol 816 + input matrix), where score corresponds to average silhouette width for a given scRNA-seq 817
protocol -input matrix pair. Protocol and input matrix are factors, with reference level Quartz-818
Seq2 and positive control, respectively. We fitted two separate linear model for transcription 819 factor and pathway activity inference methods. We report the estimates and p values for the 820 different coefficients of these linear models. Based on these linear models, we performed a 2-821 way ANOVA, and pairwise comparisons using Tukey HSD post hoc test. 822 823 824
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